SCCA2 Antibodies

Santa Cruz Biotechnology offers a broad range of SCCA2 monoclonal antibodies for investigating SCCA2 in various biological processes. SCCA2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SCCA2, or squamous cell carcinoma antigen 2, belongs to the serpin family and regulates proteolytic activity in tissues. Research has shown SCCA2's involvement in various pathological conditions, including cancer, where it influences tumor progression and immune response. Understanding SCCA2 function is essential for developing targeted therapies and improving diagnostic methods in oncology. SCCA2 expression patterns can provide valuable insights into disease mechanisms and potential therapeutic targets. Ongoing research continues to reveal new aspects of SCCA2's biological significance and potential clinical applications. SCCA2 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cancer biology and therapeutic development.